Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot StudyMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Blood|2013Cited by 0
Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot StudyMarie Y. Detrait, Mauricette Michallet, Isabelle Tigaud et al.|Blood|2012Cited by 0
High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological MalignanciesMauricette Michallet, Yves Bertrand, Mohamad Sobh et al.|Blood|2012Cited by 0